ZeaVision’s new program, QuantifEYE®, now gives Dr. Gindi the means to determine potential risk for Age-related Macular Degeneration (AMD). Now our patients can receive a comprehensive risk assessment that includes an evaluation of potential health/history factors, measurement of their macular pigment levels, and a retinal exam. This approach ensures everything possible is being done to aid in the prevention of this devastating disease.

This program is affordable, results are measurable, and testing is convenient. Baby Boomers are a generation now facing the challenges of AMD. They are also more likely to be proactive in researching their options for intervention. Early risk assessment and prevention needs to start with patients in their 20’s. Our professionals now have the ability to assess risk for AMD, take a proactive approach by providing a professionally formulated supplement to help reduce the risk for developing this debilitating disease.

The program allows for both Dr. Gindi and her patients to see the positive benefits of supplementation on follow-up visits by measuring the change in macular pigment (a key risk factor for many ocular diseases.)

This PDF requires a free plugin that may have come included with your browser. If you are having difficulties opening this file Click Here to go to Adobe's web site for Acrobat Reader.